Intravascular Lithotripsy Market Size & Share, by Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease); End User (Hospitals, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 5366
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Intravascular Lithotripsy Market size was valued at USD 212.54 million in 2024 and is expected to reach USD 659.42 million by 2037, expanding at around 9.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of intravascular lithotripsy is assessed at USD 228.98 million.

The growth of this market can be attributed on the account of growing prevalence of cardiovascular diseases all across the globe. Cardiovascular diseases, such as coronary heart disease and peripheral artery disease, are increasing worldwide due to unhealthy lifestyles, changes in dietary habits and aging populations. This has increased the need for effective treatments and minimally invasive procedures such as angioplasty or stenting, thus raising the demand for intravascular lithotripsy. According to WHO, cardiovascular disease is the leading cause of death worldwide, with about 17.9 million deaths each year.

Furthermore, the escalating existence of complexities associated with kidney stones is the main factor driving the market expansion of intravascular lithotripsy. Besides, the growing adoption of intravascular lithotripsy in order to treat patients with coronary artery disease and constant ongoing research and development in intravascular lithotripsy further is positively influencing the market growth in the projected time frame. 

INTRAVASCULAR LITHOTRIPSY
Discover Market Trends & Growth Opportunities: Request Free Sample PDF


Intravascular Lithotripsy Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

9.1%

Base Year Market Size (2024)

USD 212.54 million

Forecast Year Market Size (2037)

USD 659.42 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Intravascular Lithotripsy Segmentation

Application Type (Coronary Artery Disease, Kidney Disorder, Facilitated Vascular Access, Peripheral Arterial Disease)

Intravascular lithotripsy market from the coronary artery disease segment is set to hold the largest revenue share of 40 % by the end of 2037. Coronary heart disease is one of the most common types of cardiovascular disease and is the third leading cause of death worldwide. The high incidence of coronary heart disease has led to an increased demand for effective treatments such as intravascular lithotripsy. Intravascular lithotripsy is very effective in treating calcified plaque, a common complication of coronary artery disease. The ability of intravascular lithotripsy to safely and effectively treat calcified plaque  makes it the preferred treatment option for patients with coronary artery disease.

End User (Hospitals, Specialty Clinics)

Based on end user, the specialty clinics segment in the intravascular lithotripsy market is predicted grow substantially during the time period between 2025 – 2037. Specialty clinics focus on specific medical conditions or procedures, such as cardiovascular disease. Highly qualified medical professionals often use them. This focus allows them to provide exceptional care to patients requiring intravascular lithotripsy. Specialty clinics are often more accessible, less complicated, and more convenient for patients than hospitals. This convenience makes it easier for patients to find treatment methods, thereby contributing to the revenue growth of the specialized clinic segment in the market. Specialty clinics often have shorter wait times for appointments and procedures than hospitals, which can benefit patients who need intravascular lithotripsy. Reducing wait times can increase patient satisfaction and encourage more patients to seek care at specialty clinics. Specialty clinics typically have lower overhead costs than hospitals, which results in lower procedure costs for patients.

Our in-depth analysis of the global market includes the following segments:

                           Application Type

  • Coronary Artery Disease
  • Kidney Disorder
  •  Facilitated Vascular Access
  •  Peripheral Arterial Disease

                           End User

  • Hospitals
  • Specialty Clinics
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.


Intravascular Lithotripsy Industry - Regional Synopsis

North America Market Forecasts

North America industry is expected to hold largest revenue share of 35% by 2037. North America has a favorable reimbursement policy for intravascular lithotripsy procedures, which encourages healthcare providers to offer intravenous lithotripsy as a viable treatment option. North America has a highly developed healthcare system and the region is at the forefront of rapid adoption of technological developments. Additionally, an increasing number of people suffering from kidney and cardiac disorders is also driving the growth market in this region during the estimated time period. In the United States one person in every 33 seconds loses their life to cardiac disorder.

Asia Pacific Market Statistics

The intravascular lithotripsy market in the Asia Pacific region is estimated to witness a significant market share during the time period between 2025 – 2037. The growth of this market can be primarily driven by the account of increasing awareness about intravascular lithotripsy among the people of this region along with changes in the lifestyle that results in a higher number of people suffering from chronic illness. Furthermore, rising healthcare expenditure in the region is also driving the growth of the market in the APAC region during the projected timeframe.   

INTRAVASCULAR LITHOTRIPSY MARKET  Trends
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Intravascular Lithotripsy Landscape

    • Shockwave Medical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AVS
    • Cardiovascular Systems, Inc.
    • Abbott Laboratories
    • Siemens AG
    • Olympus America
    • Boston Scientific
    • Medispec Ltd
    • Dornier MedTech GmbH
    • Elmed Electronics & Medical Industry & Trade Inc.

Recent Developments

  • AVS announced the closing of $8.8 million in new funding, bringing its Series B funding round to $28.8 million. The funding will continue to support clinical trials of the company's pulsed intravascular lithotripsy (PIVL) device in peripheral settings, while also advancing preclinical research to expand indications in coronary cases. In September 2022, AVS successfully enrolled, processed and collected favorable 30-day follow-up data from patients in the first-in-human POWER PAD I clinical trial. Prospective, multicenter, single-arm feasibility study evaluated the technical and clinical effectiveness of the PULSETM IVL System in the treatment of patients with femoral popliteal artery calcification.
  • Shockwave Medical, Inc. announced full commercial product availability in the United States for the Shockwave L6 peripheral IVL catheter following FDA clearance. The Shockwave L6 catheter is specifically designed to correct calcification of refractory lesions in large peripheral vessels, including the common iliac and femoral arteries. Calcification of these arteries is common and is associated with decreased procedural success and increased complications with standard intravascular techniques.
  • Report ID: 5366
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intravascular lithotripsy is assessed at USD 228.98 million.

The intravascular lithotripsy market size was valued at USD 212.54 million in 2024 and is expected to reach USD 659.42 million by 2037, expanding at around 9.1% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of cardiovascular disease and increasing research and development in intravascular lithotripsy will boost the market growth.

North America industry is expected to hold largest revenue share of 35% by 2037, due to favorable reimbursement in the region.

The major players in the market are Abbott Laboratories, Siemens AG, Olympus America, Boston Scientific, Medispec Ltd, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc., and others.
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.


Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos